Esperion Therapeutics, Inc.·4

Jan 3, 4:27 PM ET

Bartram Richard 4

4 · Esperion Therapeutics, Inc. · Filed Jan 3, 2020

Insider Transaction Report

Form 4
Period: 2020-01-02
Bartram Richard
Chief Financial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2020-01-02+33,90033,900 total
    Exercise: $61.34Exp: 2020-01-02Common Stock (33,900 underlying)
  • Award

    Common Stock

    2020-01-02+7,52518,673 total
Footnotes (1)
  • [F1]The award will vest over a four (4) year period in equal quarterly installments, the first of which will be on April 2, 2020.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -